SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10-Q, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10QSB
FOR THE QUARTER ENDED JANUARY 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10QSB FOR THE QUARTER ENDED JANUARY 31, 1998.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-START>                             MAY-01-1997
<PERIOD-END>                               JAN-31-1998
<CASH>                                          29,355
<SECURITIES>                                         0
<RECEIVABLES>                                  165,995
<ALLOWANCES>                                    74,150
<INVENTORY>                                    153,573
<CURRENT-ASSETS>                               295,331
<PP&E>                                       1,498,952
<DEPRECIATION>                                 457,514
<TOTAL-ASSETS>                               1,347,626
<CURRENT-LIABILITIES>                          418,674
<BONDS>                                        190,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                     707,494
<TOTAL-LIABILITY-AND-EQUITY>                 1,347,626
<SALES>                                      2,883,441
<TOTAL-REVENUES>                             2,883,441
<CGS>                                        1,334,542
<TOTAL-COSTS>                                2,491,852
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,471
<INCOME-PRETAX>                                366,118
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            366,118
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   366,118
<EPS-BASIC>                                        .09
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission